Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (31-40 of 383) with videos related to

Pageof 39
Sort By:
BMJ Case Reports|November 12, 2024
(Intravascular) papillary endothelial hyperplasia or Masson's tumour of the axilla in a patient with a history of breast cancerMaxime Van Houdt, Tom Fidlers, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Why should results from metastatic trials no longer matter for early-stage disease?Anne-Sophie Dieudonné, Diether Lambrechts, Hans Wildiers, et al.
Annals of Translational Medicine|April 21, 2023
Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?Karen Van Baelen, Christine Desmedt, Hans Wildiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Fertility preservation in (breast) cancer patients: is it safe?Hans Wildiers, Patrick Neven, Frederic Amant, et al.
European Journal of Breast Health|April 20, 2019
Juvenile Papillomatosis: A Case ReportValerie Vandeweerd, Machteld Keupers, Griet Hoste, et al.
International Journal of Surgery Case Reports|January 23, 2017
Numb chin syndrome as a sign of mandibular metastasis: A case reportThomas Aerden, Koenraad Grisar, Patrick Neven, et al.
Breast Cancer Research and Treatment|February 13, 2016
Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigmLynn Jongen, Robert Paridaens, Giuseppe Floris, et al.
Fertility and Sterility|March 3, 2009
Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancerPatrick Neven, Frederik Amant, Willy Poppe, et al.
Endocrine-Related Cancer|January 18, 2014
Aromatase inhibitors in the breast cancer clinic: focus on exemestaneKathleen Van Asten, Patrick Neven, Anneleen Lintermans, et al.
Cancer|July 23, 2003
Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated womenDirk Timmerman, Patrick Neven, Jan Deprest, et al.
Pageof 39

Showing results (31-40 of 383) with videos related to

Sort By:
Pageof 39
BMJ Case Reports|November 12, 2024
(Intravascular) papillary endothelial hyperplasia or Masson's tumour of the axilla in a patient with a history of breast cancerMaxime Van Houdt, Tom Fidlers, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Why should results from metastatic trials no longer matter for early-stage disease?Anne-Sophie Dieudonné, Diether Lambrechts, Hans Wildiers, et al.
Annals of Translational Medicine|April 21, 2023
Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?Karen Van Baelen, Christine Desmedt, Hans Wildiers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Fertility preservation in (breast) cancer patients: is it safe?Hans Wildiers, Patrick Neven, Frederic Amant, et al.
European Journal of Breast Health|April 20, 2019
Juvenile Papillomatosis: A Case ReportValerie Vandeweerd, Machteld Keupers, Griet Hoste, et al.
International Journal of Surgery Case Reports|January 23, 2017
Numb chin syndrome as a sign of mandibular metastasis: A case reportThomas Aerden, Koenraad Grisar, Patrick Neven, et al.
Breast Cancer Research and Treatment|February 13, 2016
Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigmLynn Jongen, Robert Paridaens, Giuseppe Floris, et al.
Fertility and Sterility|March 3, 2009
Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancerPatrick Neven, Frederik Amant, Willy Poppe, et al.
Endocrine-Related Cancer|January 18, 2014
Aromatase inhibitors in the breast cancer clinic: focus on exemestaneKathleen Van Asten, Patrick Neven, Anneleen Lintermans, et al.
Cancer|July 23, 2003
Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated womenDirk Timmerman, Patrick Neven, Jan Deprest, et al.
Pageof 39